The clinical relevance of medication safety advices for drugs in liver cirrhosis and implementation in clinical decision support in pharmacy practice
- At: 2017 FIP Congress in Seoul (South Korea)
- Type: Presentation
- By: BORGSTEEDE, Sander (Health Base, Medication Safety and Information Systems, Houten, Netherlands)
- Co-author(s): Rianne Weersink
Sandra van Putten
We combined literature review with assessment by an expert panel. Drugs were classified in one of the categories: safe; no additional risks known; additional risks known; unsafe; and unknown. Recommendations were categorized by the severity of cirrhosis. An advice was considered clinically relevant if action by a prescriber or pharmacist.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.